Retinal pigment epithelial cell sheet and method for producing same

Mechanical separation and temperature-sensitive culture techniques enhance retinal pigment epithelial cell isolation, producing active and homogeneous cell sheets for effective transplantation and tissue repair.

JP7586714B2Active Publication Date: 2024-11-19BOE TECHNOLOGY GROUP CO LTD
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
JP2020572837
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-02-28
Filing Date
2020-01-22
Publication Date
2024-11-19
Estimated Expiration
2040-01-22

AI Technical Summary

Technical Problem

Existing methods for isolating and culturing retinal pigment epithelial cells face challenges in obtaining large quantities of highly active cells due to enzymatic digestion difficulties and scaffold materials causing inflammation, leading to low therapeutic efficiency and tissue lesions.

Method used

A method involving mechanical separation of retinal pigment epithelial cells using multi-well plates coated with fetal bovine serum, followed by temperature-sensitive culture dishes to form cell sheets without enzymatic digestion, maintaining cell activity and homogeneity.

Benefits of technology

The method produces retinal pigment epithelial cell sheets with high activity and homogeneity, suitable for transplantation, retaining extracellular matrix and cell connections, and secreting beneficial cytokines for tissue repair.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007586714000001
    Figure 0007586714000001
  • Figure 0007586714000002
    Figure 0007586714000002
  • Figure 0007586714000003
    Figure 0007586714000003
Patent Text Reader

Abstract

The present disclosure relates to a method for isolating retinal pigment epithelial cells, and also to a method for isolating retinal pigment epithelial cells by the isolation method and using the isolated cells to prepare a cell sheet. The present disclosure also relates to a retinal pigment epithelial cell sheet obtained by the method of the present disclosure and the use of the cell sheet in the treatment of related diseases.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] This application claims priority to a Chinese patent application bearing application number CN201910149326.3, filed on February 28, 2019, and entitled "Retinal Pigment Epithelial Cell Sheet and Method for Preparing the Same," the disclosure of which is incorporated herein by reference in its entirety.

[0002] The present disclosure relates to the fields of tissue engineering and regenerative medicine, in particular to a method for isolating retinal pigment epithelial cells and a method for producing a retinal pigment epithelial cell sheet. The present disclosure also relates to a retinal pigment epithelial cell sheet isolated by the method of the present disclosure, and the use of the cell sheet in the treatment of associated diseases. [Background technology]

[0003] For eye diseases associated with the damage or loss of retinal pigment epithelial cells, such as retinal degenerative diseases, retinal pigment cell transplantation is one of the important treatments. However, a method to obtain a large amount of highly active retinal pigment epithelial cells for transplantation is an urgent issue in this field.

[0004] The conventional method for isolating and culturing retinal pigment epithelial cells mainly uses the chemical method of trypsin digestion, and one of its disadvantages is that it cannot effectively obtain a large amount of active retinal pigment epithelial cells from the retinal pigment layer. Meanwhile, the time of enzyme digestion is difficult to control; if the time is too short, the tissue is not completely digested and not enough cells are obtained, and if the time is too long, the activity of the cells is reduced and high activity cells cannot be obtained. However, in transplantation applications, the quantity and quality of retinal pigment epithelial cells are important factors that determine the effect of cell transplantation. Therefore, it is particularly important to improve the cell isolation and culture method in order to obtain a relatively large amount of homogeneous and highly active retinal pigment epithelial cells.

[0005] In addition, when transplanting retinal pigment epithelial cells, direct injection of cells will result in the loss of many cells, leading to low therapeutic efficiency. Meanwhile, transplantation after combining cells with tissue engineering scaffold materials has solved the problem of cell loss, but the scaffold materials may cause various degrees of inflammation in vivo, and the degradation process and degradation products of the scaffold materials may cause lesions in local tissues. Therefore, the application of retinal pigment epithelial cells and related products is still needed in the art. Summary of the Invention

[0006] In one aspect, the present disclosure provides a method for producing a method for manufacturing a semiconductor device comprising: A method for obtaining retinal pigment epithelial cells, a. providing a posterior chamber goblet tissue; b. removing the retinal tissue and isolating the pigment epithelium tissue; c. mincing the pigment epithelium tissue, dispersing it by mechanical means, and then spreading it onto a multi-well plate pre-coated with fetal bovine serum; d. incubating the multi-well plate for a sufficient time to allow retinal pigment epithelial cells to migrate from the dispersed tissue block; The present invention relates to a method for isolating retinal pigment epithelial cells that does not include a step of enzymatic digestion of tissue or cells.

[0007] In some embodiments, the multi-well plate used in step c is pre-coated with a high concentration of fetal bovine serum, for example, a concentration of at least 70%, at least 80%, at least 95% or 100% fetal bovine serum can be used to pre-coat the multi-well plate and used in the method of isolating retinal pigment epithelial cells of the present disclosure.

[0008] In some embodiments, the pre-coating time for the multi-well plate may be, for example, 6 hours or more. For example, the pre-coating time may be 6-48 hours, or 12-24 hours.

[0009] The multi-well plate can be pre-coated under typical conditions for culturing cells. For example, the pre-coating of the multi-well plate can be carried out at a temperature of about 37° C. and 5% CO2, for example in an incubator.

[0010] In the process of in vitro construction, the disclosed method avoids the use of enzymes such as pancreatin to digest the tissue, and simply uses a mechanical separation method to separate the melanin epithelial tissue from the eye in a relatively gentle manner. The separated tissue block is cultured on a pre-coated adherent culture dish so that the cells autonomously migrate from the tissue block. This method avoids damage to tissue cells by enzymes, reduces contamination with other cells, and improves the activity and homogeneity of the obtained retinal pigment epithelial cells compared to cells obtained by conventional separation methods.

[0011] In another aspect, the present disclosure provides a method for producing a method for manufacturing a pharmaceutical composition comprising: A method for obtaining a retinal pigment epithelial cell sheet, comprising: a. isolating retinal pigment epithelial cells by the method of any one of claims 1-4; b. Culturing and passaging the retinal pigment epithelial cells; c. seeding the retinal pigment epithelial cells onto a temperature-sensitive culture dish pre-coated with a serum-containing medium; d. A method for producing a retinal pigment epithelial cell sheet, comprising the step of culturing the temperature-sensitive culture dish for a certain period of time and then detaching the retinal pigment epithelial cells from the culture dish by lowering the temperature.

[0012] The cell sheet technology is a technology that separates amplified and fused cells from the bottom of a culture dish by a physical method of changing temperature, and obtains a sheet-like cell structure. Compared with the conventional cell collection method by trypsin digestion, cells collected using this technology retain structures such as extracellular matrix secreted during the in vitro culture process, cell-matrix connections established, and cell-cell connections.

[0013] In one embodiment of the above-mentioned method for producing the cell sheet, in step b, the retinal pigment epithelial cells are cultured using a mixed medium of DMEM / F12 medium and high-sugar DMEM medium.

[0014] In one embodiment, the ratio of DMEM / F12 medium and high sugar DMEM medium in the mixed medium ranges from 1:5 to 5:1. For example, the ratio of DMEM / F12 medium and high sugar DMEM medium can be 1:4-4:1, 1:3-3:1, 1:2-3:1, 1:1-3:1, 1:1-2:1; 2:1-4:1, or 2:1-3:1. In one embodiment, the ratio of DMEM / F12 medium and high sugar DMEM medium can be about 1:4, about 1:3, about 1:2, about 1:1, about 2:1, about 3:1, or about 4:1.

[0015] In some embodiments, a specific ratio of serum and other cytokines and additives is added to the mixed medium, for example, 10% serum can be added to the mixed medium, and / or a cytokine selected from EGF, bFGF, and B27 can be added.

[0016] In one embodiment, the retinal pigment epithelial cells are cultured and passaged to obtain a sufficient amount of retinal pigment epithelial cells to prepare a cell sheet. For example, in step c, retinal pigment epithelial cells of passage number P2-P15 can be used. In one embodiment, the passage number of the retinal pigment epithelial cells used in step c is P3-P10.

[0017] In one embodiment, when the retinal pigment epithelial cells are seeded on a temperature-sensitive culture dish, the cell density can be controlled to better obtain a cell sheet. For example, in step c, the seeding density of the retinal pigment epithelial cells is 1×10 6 From 1×10 7 For example, the seeding density may be about 5×10 cells / ml. 6 cells / ml or approximately 6 x 10 6 It may be cells / ml.

[0018] Depending on the size of the culture dish, different amounts of retinal pigment epithelial cells can be inoculated. For example, for a 35 mm culture dish, about 2 ml of retinal pigment epithelial cells at the above density can be inoculated, for a 60 mm culture dish, about 3 ml of retinal pigment epithelial cells at the above density can be inoculated, and for a 100 mm culture dish, about 5 ml of retinal pigment epithelial cells at the above density can be inoculated.

[0019] In one embodiment, the temperature-sensitive culture dish is pre-coated with a serum-containing medium before inoculation to improve cell attachment to the culture dish. In one embodiment, the temperature-sensitive culture dish is pre-coated with a medium containing 5%-30%, such as 10%-20%, such as about 10% serum. Pre-coating of the temperature-sensitive culture dish can be performed with the same medium or a different medium used for cell culture.

[0020] In some embodiments, the pre-coating time of the temperature sensitive culture dish may be, for example, 6 hours or more, for example, the pre-coating time may be 6-48 hours, such as 12-36 hours, for example, 12-24 hours or 24-36 hours.

[0021] The temperature-sensitive culture dish can be pre-coated under typical conditions for culturing cells, for example, the temperature-sensitive culture dish can be pre-coated at a temperature of about 37° C. and 5% CO 2 , for example, in an incubator.

[0022] The temperature-intelligent culture dish is mainly made by covalently coating the base of the culture dish with poly N-isopropylacrylamide (PIPAAm) polymer material. When the culture temperature reaches about 37°C, the seeded cells attach to the wall and grow. When the temperature drops below about 32°C, the polymer material in the coating changes from a hydrophobic state to a hydrophilic state, and the cell sheet changes from an attached state to a dissociated state, allowing an intact cell sheet to be obtained without enzymatic digestion.

[0023] In step d, the temperature of the temperature-sensitive culture dish can be reduced using various methods. This allows the retinal pigment epithelial cells to be separated from the culture dish and form a cell sheet. In one embodiment, in step d, the medium is removed, and pre-cooled HBSS buffer, for example, pre-cooled HBSS buffer at 4°C is added to the temperature-sensitive culture dish to reduce the temperature, thereby detaching the retinal pigment epithelial cells from the culture dish.

[0024] In one aspect, the present disclosure relates to a retinal pigment epithelial cell sheet produced by the method of the present disclosure. The retinal pigment epithelial cell sheet obtained by the separation method and cell sheet production method of the present disclosure retains the extracellular matrix secreted during the in vitro culture process, the cell-matrix connection established, and the cell-cell connection structure, and the retinal pigment epithelial cells have high activity and homogeneity, making them suitable for applications such as transplantation.

[0025] In one embodiment, the cell sheet has a surface (top surface) that does not contact the culture dish during the fabrication process and a basal surface (bottom surface) that contacts the culture dish, the basal surface being rich in cellular connexins and relatively rough. The rough basal surface provides greater frictional force and helps the cell sheet to better adhere to the application site during application.

[0026] In one embodiment, the cell sheet is enriched in fibronectin and integrin β1.

[0027] In some embodiments, the retinal pigment epithelial cells in the cell sheet can secrete various cytokines, such as angiogenic factors and immunomodulatory factors, including one or more of hepatocyte growth factor (HGF), interleukin-6 (IL-6), interleukin-8 (IL-8), and vascular endothelial growth factor (VEGF).

[0028] In one aspect, the present disclosure relates to a method of treating an eye disease associated with damage or loss of retinal pigment epithelial cells in a subject in need thereof, comprising applying a retinal pigment epithelial cell sheet of the present disclosure to an eye of said subject.

[0029] In some embodiments, the ocular disease may be selected from age-related macular degeneration, retinitis pigmentosa, diabetic retinopathy, retinal detachment, central retinal artery occlusion, central retinal vein occlusion, retinal atrophy, retinal pigment epithelium detachment, uveitis, and degenerative myopia.

[0030] In another aspect, the present disclosure relates to use of a retinal pigment epithelial cell sheet of the present disclosure in treating an ocular disease associated with damage or loss of retinal pigment epithelial cells in a subject.

[0031] In yet another aspect, the present disclosure relates to use of the retinal pigment epithelial cell sheet of the present disclosure in preparing a pharmaceutical composition for treating an ocular disease associated with damage or loss of retinal pigment epithelial cells in a subject.

[0032] In certain embodiments of the above uses, the eye disease may be selected from age-related macular degeneration, retinitis pigmentosa, diabetic retinopathy, retinal detachment, central retinal artery occlusion, central retinal vein occlusion, retinal atrophy, retinal pigment epithelium detachment, uveitis, and degenerative myopia. [Brief description of the drawings]

[0033] [Figure 1] FIG. 1 shows a dashed line graph of the proliferation over time of retinal epithelial cells cultured by the culture method of the present disclosure and cells cultured using conventional medium. [Diagram 2] Figure 2 shows the results of staining the cultured cells with the corresponding antibodies by fluorescence microscopy: Figure 2A shows the staining results for the epithelial cell specific marker CK19, Figure 2B shows the staining results for nestin, and Figure 2C shows the staining results for RPE-65. [Diagram 3] Figure 3 shows the molecular expression detection results of the cultured cells by flow cytometry, including the detection results of the expression of CD14, HLA-DR, CD44, CD34, and CD45 in the cells. [Figure 4] FIG. 4 shows the results of cell cycle analysis of a population of retinal pigment epithelial cells at passage P8. [Diagram 5]FIG. 5 shows the results of detecting proliferation of retinal pigment epithelial cells by Ki67 staining. [Figure 6] Figure 6 shows scanning electron microscopy imaging of a retinal pigment epithelial cell sheet: Figure 6A: upper surface of the cell sheet; Figure 6B: lower (basal) surface of the cell sheet. [Figure 7] Figure 7 shows immunofluorescence imaging pictures of retinal pigment epithelial cell sheets: Figure 7A: Fibronectin; Figure 7B: Integrin β1. [Figure 8] FIG. 8 shows the results of detecting cytokine expression in the culture supernatant of a retinal pigment epithelial cell sheet using the ELISA method. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0034] The present invention will be further described below with reference to specific embodiments, and the advantages and features of the present invention will become more apparent with the description. However, these embodiments are merely illustrative and do not constitute any limitation on the scope of the present invention. Those skilled in the art should understand that the details and forms of the technical solutions of the present invention can be modified or replaced without departing from the spirit and scope of the present invention, and these modifications and replacements are within the protection scope of the present invention. EXAMPLES

[0035] Example 1. Isolation of retinal pigment epithelial cells Existing methods for preparing retinal pigment epithelial cells cause relatively large damage to cells during the process of obtaining materials, and the primary cells obtained are small in quantity and of poor quality. In this embodiment, the tissue block is mechanically broken and the tissue block is cultured so that the retinal pigment epithelial cells can autonomously migrate. In this method, one of the important factors to be considered is how to completely attach the tissue block to the wall. The method of this embodiment includes the following steps.

[0036] Pre-coating of multi-well plates: Pre-coat 6-well plates with 100% fetal bovine serum and add 1 ml of fetal bovine serum to each well. Incubate the 6-well plates at 37° C. in a 5% CO2 cell incubator.

[0037] Tissue isolation: Isolate the posterior chamber goblet tissue from the aborted fetus, wash the posterior chamber goblet tissue with sterile phosphate-buffered saline (PBS) and cut into plum slices. After removing the retinal tissue, peel off the pigment epithelium layer tissue. Place the peeled tissue into a 35 mm culture dish and add a small amount of medium. Cut the tissue repeatedly with ophthalmic microbending scissors and add a small amount of medium to the cut tissue.

[0038] Tissue attachment: Remove the pre-coated 6-well plate and aspirate and discard the coating solution. Disperse the tissue using a sharp pipette and inoculate the tissue suspension into the coated 6-well plate. Place the 6-well plate in an incubator and incubate at 37 °C, 5% CO2.

[0039] Example 2. Cultivation of retinal pigment epithelial cells In the case of retinal pigment epithelial cells, the conventional culture method uses DMEM / F12 medium supplemented with 10% serum, which has problems such as time-consuming cell culture, normal cell purity, and low activity. In this example, the culture medium was improved.

[0040] The characteristic of the conventional DMEM / F12 medium is that it adds trace elements and inorganic ions to the formula to increase the nutritional value of the medium, while the high-sugar DMEM medium is more suitable for primary cell culture and promotes cell growth in vitro. In this embodiment, a mixed medium of DMEM / F12 medium and high-sugar DMEM medium is used for cell culture, and the mixed medium contains 60% DMEM / F12 medium, 30% high-sugar DMEM medium, and 10% serum. In addition, EGF (4ng / ml), bFGF (4ng / ml), and B27 (2ml / 100ml) were added as supplements. As shown in Figure 1, it was found that the use of this mixed medium accelerated the proliferation rate of retinal pigment epithelial cells, and the proliferation state of the cells was better than that of cells cultured in the conventional DMEM / F12 medium.

[0041] Example 3. Characterization of retinal pigment epithelial cells Morphological identification of retinal pigment epithelial cells subcultured in vitro was performed. Cells isolated and subcultured in vitro maintained epithelial cell-like morphology, and most cells were monolayered and polygonal. Some cells were long spindle-shaped. Primary isolated retinal pigment epithelial cells had melanin particles and good adhesion and viability rates within 15 generations. With the increase in cell generations, the cells gradually lost melanin particles.

[0042] In addition, markers of the cultured retinal pigment epithelial cells were identified by fluorescent staining, and the results are shown in Figure 2. The results in this figure show that the isolated and cultured cells express epithelial cell-specific markers CK19 (Figure 2A), nestin (a characteristic of stem cells; Figure 2B), and RPE-65 (Figure 2C).

[0043] Furthermore, the expression of marker molecules of a portion of the isolated cell population was detected by flow cytometry. As shown in the results of FIG. 3, the isolated cells were strongly positive for CD44, but negative for CD14, CD34, CD45, and HLA-DR. CD44 positivity indicates that the cultured retinal pigment epithelial cells have strong proliferation, adhesion, and migration abilities in vitro. CD14 negativity indicates that the cultured retinal pigment epithelial cells are not contaminated by endothelial cells. CD34 and CD45 negativity indicates that the cell population does not contain hematopoietic cells. HLA-DR negativity indicates that the cultured retinal pigment epithelial cells do not express human leukocyte antigens and therefore have low immunogenicity. The above results indicate that the retinal pigment epithelial cells isolated by the method of the present disclosure are suitable for use in transplantation applications.

[0044] Before producing the cell sheet, the proliferation state of the cultured retinal pigment epithelial cells was detected. Figure 4 shows the ratio of cells at each stage of the cell cycle in a population of retinal pigment epithelial cells at passage number P8. In particular, the ratio of cells in the S phase (DNA synthesis phase) was relatively high at 18.47 ± 4.95%, indicating that the cells in this population have strong cell proliferation ability.

[0045] Figure 5 shows the staining of cultured cells with Ki67 antibody. Ki67 is a marker for cells undergoing proliferation. The staining results indicate that many cells in the cultured RPE cell population are undergoing proliferation and are in an active cell state.

[0046] Example 4. Preparation of cell sheets The retinal pigment epithelial cell sheet was prepared in the following steps. Pre-coating temperature-sensitive culture dishes: Pre-coat temperature-sensitive culture dishes using medium containing 10% serum. For 35 mm culture dishes, add 2 ml of serum-containing medium, for 60 mm culture dishes, add 3 ml of serum-containing medium, and for 100 mm culture dishes, add 5 ml of serum-containing medium. Place the culture dishes in a 37°C, 5% CO2 incubator for pre-coating. The pre-coating time is 12-24 hours.

[0047] Cell inoculation: Digest and count cultured retinal pigment epithelial cells to ensure that the cell concentration in the suspension is 6x10 6 Resuspend the cells in medium to 100 cells / ml. Remove the pre-coated temperature-sensitive culture dish, discard the coating solution, and inoculate the cells onto the temperature-sensitive culture dish. For a 35 mm culture dish, add 2 ml of the suspension at the above cell concentration, for a 60 mm culture dish, add 3 ml of the cell suspension, and for a 100 mm culture dish, add 5 ml of the cell suspension. Place the culture dish in a 37°C, 5% CO2 incubator and culture for 12-36 hours to allow the retinal pigment epithelial cells to attach to the culture dish and proliferate.

[0048] Preparation of the sheet: Remove the temperature-sensitive culture dish, discard the culture medium, and add HBSS buffer pre-cooled to 4°C. Add 2 ml of HBSS buffer for a 35 mm culture dish, add 3 ml of HBSS buffer for a 60 mm culture dish, and add 5 ml of HBSS buffer for a 100 mm culture dish. After about 10 minutes, the cells will detach from the edge of the dish and a cell sheet will be formed. Then, transfer the completely detached cell sheet to a general culture dish and add HBSS buffer to wash the membrane 2-3 times. Store the prepared sheet at 4°C.

[0049] Compared with conventional retinal pigment epithelial cell products, no cell digestive enzymes are used to digest the cells during the preparation of the sheet, so cell activity is largely preserved. At the same time, the prepared cell sheet retains the extracellular matrix secreted during the culture process, the cell-matrix connection established, and the cell-cell connection structure, which has beneficial effects on the subsequent application of the sheet.

[0050] Example 5. Structural characterization of retinal pigment epithelial cell sheets In this example, the structure of the prepared retinal pigment epithelial cell sheets was characterized using scanning electron microscopy and immunofluorescence imaging.

[0051] Scanning electron microscopes can modulate imaging and observe the surface structure of the fabricated cell sheet using the physical signal excited when scanning the surface of the sample with a finely focused electron beam. A retinal pigment epithelial cell sheet was fabricated by the method described in Example 4, and a scanning electron microscope sample was further prepared for imaging analysis. As shown in Figure 6, scanning electron microscope imaging shows that the structures of the upper and lower surfaces of the cell sheet are significantly different. The upper surface (Figure 6A) is formed with a smooth surface due to the cells naturally sinking. The lower surface (basal surface, Figure 6B) comes into contact with the temperature-sensitive culture dish, is rich in cell connexins, and has a relatively rough surface. Due to its structural characteristics, the basal surface can provide greater friction, which is beneficial for the cell sheet to better adhere to the application site during application.

[0052] The expression of fibronectin and integrin β1 in the retinal pigment epithelial cell sheet was further detected by immunofluorescence. The cell sheet prepared by the method described in Example 4 was fixed and frozen sectioned, stained with fluorescein-labeled fibronectin and integrin β1 antibodies, and subjected to immunofluorescence imaging analysis. The detection results are shown in Figure 7, and the cell sheet prepared by the method of the present disclosure contains a large amount of fibronectin (Figure 7A) and integrin β1 (Figure 7B).

[0053] Fibronectin is widely present in animal tissues and tissue fluids and has the function of promoting cell adhesion and proliferation, which is a necessary condition for maintaining and repairing the tissue structure of the body. Integrin β1 is an important member of the integrin family, plays an important role in mediating mutual adhesion between cells and between cells and extracellular matrix (ECM), and bidirectional signal transmission between cells and ECM, and is closely related to tissue repair and fibrosis formation. The results show that the retinal pigment epithelial cell sheet prepared by the method of the present disclosure is a sheet with dense tissue and biological activity formed not simply by cell accumulation but by the connection of the extracellular matrix. Furthermore, the high level of expression of fibronectin and integrin β1 in the cell sheet indicates that the cell sheet has the function of tissue repair and can be used for related diseases involving damage or loss of retinal pigment epithelial cells to achieve tissue damage repair.

[0054] Example 6. Cytokine secretion from retinal pigment epithelial cell sheets To further characterize the function of the retinal pigment epithelial cells of the present disclosure, the following cytokines secreted by the retinal pigment epithelial cells were detected: hepatocyte growth factor (HGF); interleukin-6 (IL-6), interleukin-8 (IL-8) and vascular endothelial growth factor (VEGF). The above cytokines have the function of promoting cell proliferation and differentiation, initiating and promoting the angiogenesis process, and playing an important role in tissue repair. In addition, IL-6 and IL-8 are also involved in regulating immune responses and can promote the proliferation and differentiation of immune cells.

[0055] During the preparation of the cell sheet, the culture supernatant was collected, and the cytokines in the supernatant were detected by ELISA. The detection results are shown in FIG. 8. The results showed that the above four cytokines were all expressed in the supernatant, and the expression levels of IL-6 and IL-8 were high. The above results show that the cell sheet of the present disclosure can secrete various cytokines, including angiogenic factors and immunoregulatory factors, proving that the cell sheet has high biological activity and function and can promote local angiogenesis and tissue repair processes. Furthermore, the high expression levels of IL-6 and IL-8 indicate that the cell sheet has the function of promoting immune response and inhibiting bacteria during use, which is beneficial for the cell sheet to better exert its biological function.

[0056] Although certain embodiments of the present invention have been described above, those skilled in the art should understand that these are merely examples, and the scope of the present invention is defined by the appended claims. Those skilled in the art can make various modifications or substitutions to these embodiments without departing from the principle and essence of the present invention, and all of these modifications and substitutions are within the protection scope of the present invention.

Claims

1. A method for obtaining retinal pigment epithelial cells, a. removing retinal tissue from the provided posterior chamber goblet tissue and isolating pigment epithelium tissue; b. The pigment epithelium tissue is minced, dispersed by mechanical means, and then spread onto a multi-well plate pre-coated with fetal bovine serum; c. incubating the multi-well plate for a sufficient time to allow retinal pigment epithelial cells to migrate from the dispersed tissue block; A method for isolating retinal pigment epithelial cells that does not include a step of enzymatic digestion of tissue or cells.

2. 2. The method of claim 1, wherein the multiwell plate used in step b is a multiwell plate pre-coated with 100% fetal bovine serum.

3. The method according to claim 2, wherein the pre-coating time is 12-24 hours.

4. The pre-coating is performed at about 37° C. and 5% CO 2 The method according to any one of claims 1 to 3, wherein the process is carried out under the conditions of

5. A method for obtaining a retinal pigment epithelial cell sheet, comprising: a. isolating retinal pigment epithelial cells by the method of any one of claims 1-4; b. Cultivating and passaging the retinal pigment epithelial cells; c. seeding the retinal pigment epithelial cells onto a temperature-sensitive culture dish pre-coated with a serum-containing medium; (d) A method for producing a retinal pigment epithelial cell sheet, comprising the step of culturing the temperature-sensitive culture dish for a certain period of time, and then detaching the retinal pigment epithelial cells from the culture dish by lowering the temperature.

6. The method according to claim 5, wherein in step b, the retinal pigment epithelial cells are cultured using a mixed medium of DMEM / F12 medium and high-sugar DMEM medium.

7. The method according to claim 6, wherein in the mixed medium, the ratio of DMEM / F12 medium to high-sugar DMEM medium is 1:5 to 5:

1.

8. The method according to any one of claims 5 to 7, wherein the passage number of the retinal pigment epithelial cells used in step c is P2-P15.

9. The method according to claim 8, wherein the passage number of the retinal pigment epithelial cells used in step c is P3-P10.

10. In step c, the seeding density of the retinal pigment epithelial cells is 1×10 6 From 1 x 10 7 The method of any one of claims 5 to 9, wherein the concentration is cells / ml.

11. In step c), the seeding density of the retinal pigment epithelial cells is about 6×10 6 The method of claim 10, wherein the concentration is cells / ml.

12. The method according to any one of claims 5 to 11, wherein the temperature-sensitive culture dish is pre-coated with a medium containing 10% serum.

13. The method according to any one of claims 5 to 12, wherein in step d, the temperature sensitive culture dish is incubated for 12-36 hours.

14. The method according to any one of claims 5 to 13, wherein in step d, the temperature is lowered by removing the medium and adding pre-cooled HBSS buffer to the temperature-sensitive culture dish, thereby detaching the retinal pigment epithelial cells from the culture dish.

15. A retinal pigment epithelial cell sheet produced by the method according to any one of claims 5 to 14.

16. The retinal pigment epithelial cell sheet of claim 15, wherein the retinal pigment epithelial cell sheet has a surface that does not contact the culture dish during the production process and a basal surface that contacts the culture dish, the basal surface being rich in cellular connexins and relatively rough.

17. The retinal pigment epithelial cell sheet according to claim 15 or 16, wherein the retinal pigment epithelial cell sheet is rich in fibronectin and integrin β1.

18. The retinal pigment epithelial cell sheet according to any one of claims 15 to 17, wherein the retinal pigment epithelial cells in the retinal pigment epithelial cell sheet are capable of secreting various angiogenic factors and immunoregulatory factors.

19. The retinal pigment epithelial cell sheet of claim 18, wherein the angiogenic and immunomodulatory factors include one or more of hepatocyte growth factor (HGF), interleukin-6 (IL-6), interleukin-8 (IL-8), and vascular endothelial growth factor (VEGF).

20. Use of the retinal pigment epithelial cell sheet according to any one of claims 15 to 19 in the preparation of a pharmaceutical composition for treating an eye disease associated with damage or loss of retinal pigment epithelial cells in a subject.

21. 21. The use according to claim 20, wherein the ocular disease is selected from age-related macular degeneration, retinitis pigmentosa, diabetic retinopathy, retinal detachment, central retinal artery occlusion, central retinal vein occlusion, retinal atrophy, retinal pigment epithelium detachment, uveitis, and degenerative myopia.

Citation Information

Patent Citations

  • Culture of recombinant cell

    JP1990000467A

  • Method for producing sheet-shaped cell culture

    JP2010226991A

  • Production method of sheet-like cell culture

    JP2016096732A